ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China flag China · Delayed Price · Currency is CNY
11.15
-0.07 (-0.62%)
At close: Nov 5, 2025

ChemPartner PharmaTech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
5,5523,1853,8095,1846,8827,362
Upgrade
Market Cap Growth
79.26%-16.38%-26.51%-24.68%-6.52%11.09%
Upgrade
Enterprise Value
5,6393,3704,1855,5748,3907,812
Upgrade
Last Close Price
11.156.427.6510.4113.8114.67
Upgrade
PE Ratio
---13.69-47.63
Upgrade
Forward PE
-50.4050.4050.4050.4050.40
Upgrade
PS Ratio
5.203.283.353.914.074.97
Upgrade
PB Ratio
4.352.572.612.173.463.00
Upgrade
P/TBV Ratio
4.552.693.013.5811.3110.70
Upgrade
P/FCF Ratio
44.9532.19--74.63-
Upgrade
P/OCF Ratio
31.5718.9425.2319.7518.2021.45
Upgrade
EV/Sales Ratio
5.283.473.684.204.965.27
Upgrade
EV/EBITDA Ratio
49.14--380.0347.4125.60
Upgrade
EV/EBIT Ratio
----128.4738.75
Upgrade
EV/FCF Ratio
45.6634.06--90.98-
Upgrade
Debt / Equity Ratio
0.360.420.440.410.880.47
Upgrade
Debt / EBITDA Ratio
4.0515.638.589.946.733.74
Upgrade
Debt / FCF Ratio
3.765.19--18.94-
Upgrade
Asset Turnover
0.520.440.360.330.410.38
Upgrade
Inventory Turnover
80.0539.0724.3117.9118.7414.98
Upgrade
Quick Ratio
1.931.671.481.640.561.00
Upgrade
Current Ratio
2.101.861.701.750.691.17
Upgrade
Return on Equity (ROE)
-11.81%-16.79%-47.67%17.30%-18.11%6.48%
Upgrade
Return on Assets (ROA)
-0.68%-2.74%-1.31%-1.49%0.98%3.19%
Upgrade
Return on Capital (ROIC)
-0.78%-3.16%-1.50%-1.69%1.11%3.73%
Upgrade
Return on Capital Employed (ROCE)
----2.00%6.00%
Upgrade
Earnings Yield
-2.84%-7.11%-24.07%7.30%-5.85%2.10%
Upgrade
FCF Yield
2.22%3.11%-1.32%-1.42%1.34%-0.69%
Upgrade
Dividend Yield
-----0.48%
Upgrade
Payout Ratio
---9.88%-36.94%
Upgrade
Buyback Yield / Dilution
-2.98%-1.01%-0.02%-0.31%0.64%-
Upgrade
Total Shareholder Return
-2.98%-1.01%-0.02%-0.31%0.64%0.48%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.